# Adipose Tissue and Renal Carcinoma: A Protumor Metabolic and Endocrine Alliance

**Authors:** Matías Ferrando, Daiana Lorena Moya Morales, Leonardo Rafael Romeo, Mauro Agustín Carrillo, Rocío Yasmin Cano, Silvina Esther Gómez, Constanza Matilde López-Fontana, Rubén Walter Carón, Flavia Alejandra Bruna, Virginia Pistone-Creydt

PMC · DOI: 10.3390/ijms27031528 · International Journal of Molecular Sciences · 2026-02-04

## TL;DR

This study shows how kidney cancer interacts with nearby fat tissue, causing metabolic and hormonal changes that support tumor growth.

## Contribution

The paper presents an ex vivo model showing bidirectional metabolic and endocrine interactions between clear cell renal cell carcinoma and human adipose tissue.

## Key findings

- Exposure to tumor-derived conditioned media alters adipocytokine expression and induces dedifferentiation in adipose tissue.
- Tumor-conditioned media increases lactate production and upregulates estrogen receptors in adipose tissue.
- Adipocyte browning markers and metabolic reprogramming are activated in response to tumor signals.

## Abstract

Cancer is a multifactorial disease influenced not only by genetic and epigenetic alterations but also by interactions with the surrounding microenvironment. Among the hallmarks of cancer, metabolic reprogramming enables tumor cells to adapt and survive under adverse conditions. These metabolic alterations also induce changes in stromal cells. In clear cell renal cell carcinoma (ccRCC), adipocytes are among the most abundant stromal components. We have previously shown that ccRCC progression depends on the bidirectional crosstalk between tumor epithelial cells and neighboring adipocytes. Here, we investigated the effects of ccRCC on naïve human adipose tissue (hRAN). Human retroperitoneal adipose tissue fragments from two distinct donors (n = 2) were incubated with conditioned media (CMs) derived from ccRCC tumors (T-CM) or renal epithelial cells (Tc-CM). We analyzed the expression of adipocytokines, differentiation and browning markers, metabolic parameters, and steroid hormone receptor profiles. The exposure of hRAN to T-CM or Tc-CM led to significant alterations in the expression of adiponectin and leptin, as well as markers associated with differentiation and browning, including PLIN1, HSL, PGC1α, PPARγ, and UCP1. Adipocytes from treated hRAN were smaller than those from controls, suggesting dedifferentiation. Moreover, expression of FABP4 and MCT1 was significantly increased in explants treated with T-CM compared to control media. Conditioned media from these treated hRAN samples showed elevated lactate secretion, indicating enhanced lactatogenesis. Given the role of sex hormones in metabolic regulation, we examined the expression of estrogen (ER), androgen (AR), and progesterone (PR) receptors. While AR and PR levels remained unchanged, both ERα and ERβ were significantly upregulated after T-CM treatment. Metabolic reprogramming in renal tumors induces profound adaptive changes in adjacent adipose tissue. The dedifferentiation and browning of adipocytes, altered adipocytokine expression, and increased lactate production observed in hRAN reflect the metabolic stress imposed by the tumor environment. Here, we provide evidence, using an ex vivo model, of a dynamic partnership between human adipose tissue and ccRCC tumors.

## Linked entities

- **Genes:** PLIN1 (perilipin 1) [NCBI Gene 5346], LIPE (lipase E, hormone sensitive type) [NCBI Gene 3991], PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], UCP1 (uncoupling protein 1) [NCBI Gene 7350], FABP4 (fatty acid binding protein 4) [NCBI Gene 2167], CMA1 (chymase 1) [NCBI Gene 1215], EREG (epiregulin) [NCBI Gene 2069], AR (androgen receptor) [NCBI Gene 367], PGR (progesterone receptor) [NCBI Gene 5241], ESR1 (estrogen receptor 1) [NCBI Gene 2099], ESR2 (estrogen receptor 2) [NCBI Gene 2100]
- **Diseases:** clear cell renal cell carcinoma (MONDO:0005005), renal carcinoma (MONDO:0005206)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, FABP4 (fatty acid binding protein 4) [NCBI Gene 2167] {aka A-FABP, AFABP, ALBP, HEL-S-104, aP2}, LIPE (lipase E, hormone sensitive type) [NCBI Gene 3991] {aka AOMS4, FPLD6, HSL, LHS, REH}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, SLC16A1 (solute carrier family 16 member 1) [NCBI Gene 6566] {aka HHF7, MCT, MCT1, MCT1D}, PLIN1 (perilipin 1) [NCBI Gene 5346] {aka FPLD4, PERI, PLIN}, UCP1 (uncoupling protein 1) [NCBI Gene 7350] {aka SLC25A7, UCP}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, ESR2 (estrogen receptor 2) [NCBI Gene 2100] {aka ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2}
- **Diseases:** Renal Carcinoma (MESH:D002292), Adipose Tissue (MESH:D018205), renal tumors (MESH:D007680), Cancer (MESH:D009369)
- **Chemicals:** Tc (MESH:D013667), lactate (MESH:D019344)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12898272/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12898272/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12898272/full.md

---
Source: https://tomesphere.com/paper/PMC12898272